Gladdy Lab

Our team effort to better understand #leiomyosarcoma from molecular classification🧬,metastatic progression🔬,use of DDRi💊is out today @NatureComms! Great collaboration with #AdamShlien @SickKidsNews @OICR @PMResearch_UHN @SinaiHealth 🙏to our patients rdcu.be/cpLue

Adam Shlien: An international framework for clinical translation of molecular classifiers in osteosarcoma - NPJ Precision Oncology. May 2026 app.sosido.com/articles/10332…

Incredible to learn about #sustainabilty Global leadership 🌎🌳&innovation @uoftmedicine @SustainableUofT with @Ecosurgeon @UBC visiting Tovee Professor @UofTSurgery @UofTGSx Climate and Energy change for healthcare and our U of T community

Proud to announce the new partnership between TARPSWG and @SocSurgOnc ! Together, we aim to advance global #sarcoma care through collaboration, education, and surgeon-led research in #RPS. Looking forward to new opportunities for the international sarcoma community.

A dose-reduced preoperative radiotherapy regimen (36 Gy in 18 fractions) for liposarcoma offered high local control and low rates of major late toxic effects in a phase 2 trial, supporting use in eligible patients. #ESTRO26 @ESTRO_RT ja.ma/4dnqUhr

New publication: Viewpoint: are surgeon-scientists still worth the investment? @UofTSpine @UofTSurgery @KBI_UHN @UofTNeuroSurge journals.lww.com/annals-of-medi…

Registration is now open for the #TARPSWG Semiannual Meeting 2026 in Seoul 🇰🇷 📅 November 18, 2026 📍 Seoul, South Korea 💻 In-person & remote participation available 🔗 Register here: forms.gle/C7sQuZrfwXkSYu… @ctosociety @SocSurgOnc @SoMe4sarcoma #Sarcoma #RPS #SurgicalOncology

Highlights include: • TARPSWG Lecture by Dirk Strauss on the future perspectives opened by prospective #RESAR registry data • Interactive RE-LIVE surgery sessions from INT Milan and U Toronto Mount Sinai, featuring Carol Swallow, Alessandro Gronchi, Marco Fiore

#ReSurge #RetroperitonealSarcoma surgery Masterclass. Register here essoweb.org/courses-and-we…

Interested in #RetroperitonealSarcoma surgery? Join #ReSurge2026, the @ESSOnews online course endorsed by @TARPSWG community. @alegronchi @FioreDoc #CarolJSwallow #DirkStrauss Register here: essoweb.org/courses-and-we… @IstTumori @SinaiHealth

SSO is proud to announce our partnership with @TARPSWG, a global network of 400+ members across 50 high-volume sarcoma centers. This collaboration strengthens our shared commitment to advancing global collaboration, education, and surgeon-led sarcoma research.

The #Sarculator app update is now live! This comes together with our @TheLancetOncol paper introducing #BayeSarc, a Bayesian sequential learning approach to refine prognostication in extremity soft tissue #sarcoma. Paper: sciencedirect.com/science/articl…
App: apps.apple.com/it/app/sarcula…

Does regional hyperthermia add benefit to neoadjuvant chemotherapy in extremity soft-tissue #sarcoma? A new analysis of the EORTC 62961–ESHO 95 trial provides updated survival data. Full #OpenAccess article: acsjournals.onlinelibrary.wiley.com/doi/full/10.10… @Maegges79 @OncoAlert CC: @chandrajitraut

wonderful to have Torsten Nielsen join Sarcoma Research Rounds ⁦@pmcancercentre⁩ ⁦@SinaiHealth⁩ #synovialsarcoma #chondrosarcoma

Incredibly touched by this. Please take a minute to read today. An important message for physicians everywhere

Congrats to the many CIP trainees involved with UpSurge and this paper @Bondzi23 @DavidDan_Ngn @armaan_km @KennedyAyoo @ben_li123 #sherrymahmood and others

We’re proud to be part of the Marathon of Hope Cancer Centres Network and contribute to this national effort inspired by Terry Fox. This Innovation Report showcases the progress made - and the impact it’s having on cancer research and care in Canada ➡️ bit.ly/3PFEkfa

Congratulations to Dr. Keiran Campbell, investigator at LTRI, on receiving the Canadian Society of Molecular Bioscience’s New Investigator Award (@CSMB_SCBM), recognizing his achievements and leadership in computational cancer biology 👏 #SinaiHealth #LTRI #CancerResearch

Someone took the time to review your last grant. Now it’s your turn. CIHR needs reviewers for the Spring 2026 Project Grant competition. Say “YES” when asked.

Spring is coming, as well as our CTOS Spring 2026 Webinar! This year, our panel of experts will discuss "Advances in Immunotherapy for Sarcomas" 🗓️ Tuesday, April 14th ⏳ 9am-11am EST Full program and registration ➡️ lnkd.in/e5hsiFTG You can't miss it!

Now online: Transcriptomic Subgroups in Soft Tissue Tumors Correlate with Morphologic Subtype, Genomic Features, and Outcome doi.org/10.1158/1078-0…